Annual Current Liabilities
$4.38 M
+$1.00 M+29.58%
December 1, 2023
Summary
- As of February 21, 2025, RNTX annual total current liabilities is $4.38 million, with the most recent change of +$1.00 million (+29.58%) on December 1, 2023.
- During the last 3 years, RNTX annual current liabilities has risen by +$425.00 thousand (+10.73%).
Performance
RNTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$5.66 M
+$722.00 K+14.62%
September 1, 2024
Summary
- As of February 21, 2025, RNTX quarterly total current liabilities is $5.66 million, with the most recent change of +$722.00 thousand (+14.62%) on September 1, 2024.
- Over the past year, RNTX quarterly current liabilities has increased by +$1.13 million (+24.87%).
Performance
RNTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RNTX Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +29.6% | +24.9% |
3 y3 years | +10.7% | +96.2% |
5 y5 years | -18.3% | -12.0% |
RNTX Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -2.7% | -22.8% | at high | -78.8% |
5 y | 5-year | -24.9% | -22.8% | -7.9% | -78.8% |
alltime | all time | -24.9% | -41.9% | -20.4% | -78.8% |
Rein Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $5.66 M(+14.6%) |
Jun 2024 | - | $4.94 M(+8.9%) |
Mar 2024 | - | $4.53 M(+3.4%) |
Dec 2023 | $4.38 M(+29.6%) | $4.38 M(+170.0%) |
Sep 2023 | - | $1.62 M(+35.7%) |
Jun 2023 | - | $1.20 M(-58.5%) |
Mar 2023 | - | $2.88 M(-14.8%) |
Dec 2022 | $3.38 M(-24.9%) | $3.38 M(-25.4%) |
Sep 2022 | - | $4.54 M(-11.9%) |
Jun 2022 | - | $5.15 M(+24.2%) |
Mar 2022 | - | $4.15 M(-8.0%) |
Dec 2021 | $4.51 M(+13.8%) | $4.51 M(-1.1%) |
Sep 2021 | - | $4.56 M(+6.7%) |
Jun 2021 | - | $4.27 M(+39.0%) |
Mar 2021 | - | $3.07 M(-22.4%) |
Dec 2020 | $3.96 M | $3.96 M(-24.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2020 | - | $5.25 M(+6.6%) |
Jun 2020 | - | $4.93 M(-19.8%) |
Mar 2020 | - | $6.14 M(+5.2%) |
Dec 2019 | $5.84 M(+8.7%) | $5.84 M(-9.2%) |
Sep 2019 | - | $6.43 M(+19.3%) |
Jun 2019 | - | $5.39 M(+16.5%) |
Mar 2019 | - | $4.62 M(-13.9%) |
Dec 2018 | $5.37 M(+9.8%) | $5.37 M(-24.4%) |
Sep 2018 | - | $7.11 M(+11.6%) |
Jun 2018 | - | $6.36 M(+31.1%) |
Mar 2018 | - | $4.86 M(-0.7%) |
Dec 2017 | $4.89 M(+20.1%) | $4.89 M(-2.6%) |
Sep 2017 | - | $5.02 M(-8.2%) |
Jun 2017 | - | $5.47 M(+90.6%) |
Mar 2017 | - | $2.87 M(-29.5%) |
Dec 2016 | $4.07 M(+59.7%) | $4.07 M |
Dec 2015 | $2.55 M | - |
FAQ
- What is Rein Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Rein Therapeutics?
- What is Rein Therapeutics annual current liabilities year-on-year change?
- What is Rein Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Rein Therapeutics?
- What is Rein Therapeutics quarterly current liabilities year-on-year change?
What is Rein Therapeutics annual total current liabilities?
The current annual current liabilities of RNTX is $4.38 M
What is the all time high annual current liabilities for Rein Therapeutics?
Rein Therapeutics all-time high annual total current liabilities is $5.84 M
What is Rein Therapeutics annual current liabilities year-on-year change?
Over the past year, RNTX annual total current liabilities has changed by +$1.00 M (+29.58%)
What is Rein Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of RNTX is $5.66 M
What is the all time high quarterly current liabilities for Rein Therapeutics?
Rein Therapeutics all-time high quarterly total current liabilities is $7.11 M
What is Rein Therapeutics quarterly current liabilities year-on-year change?
Over the past year, RNTX quarterly total current liabilities has changed by +$1.13 M (+24.87%)